(2S,7aR,8R,8aS,11S,11aS,11bR,11cR)-8-Ethyl-11-methyl-2-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]dodecahydroazepino[3,2,1-hi]furo[3,2-e]indol-10(2H)-one(CAS: 6879-01-2)

This compound is a crystalline solid with a high molecular weight. It is slightly soluble in organic solvents and has a low solubility in water. It is chemically stable under normal conditions but may react with strong acids or bases. It has a melting point of approximately 220°C and a density of about 1.05 g/cm³.

This compound is synthesized through a multi-step process involving condensation reactions, ring formations, and functional group transformations. Common catalysts used include Lewis acids and organometallic reagents. The reaction conditions typically include heating under an inert atmosphere, with yields ranging from 50% to 70%.

This compound is primarily used in the pharmaceutical industry for the development of novel drugs. It also shows potential in the polymer industry for specific applications requiring unique chemical properties. Additionally, it may be used in sensors and semiconductors due to its electronic and optical characteristics.

When handling this compound, appropriate personal protective equipment (PPE) should be worn, including gloves, goggles, and a lab coat. Work should be conducted in a well-ventilated fume hood. Spills should be handled with appropriate absorbents, and the Material Safety Data Sheet (MSDS) should be consulted for detailed emergency procedures. Storage should be in a cool, dry place away from heat sources and incompatible materials.